Benchtop Next-Generation Sequencer for Clinical Use

What is the Benchtop Next-Generation Sequencer for Clinical Use?

A benchtop next-generation sequencer for clinical use reads millions of DNA fragments in parallel to support gene panel testing, oncology profiling, inherited disease testing and pathogen genomics. It suits laboratories that need broad multi-gene information in one assay rather than single-target results.

Overview

This variant uses sequencing by synthesis or semiconductor detection on a flow cell or chip to read libraries prepared from patient DNA or RNA. Typical output ranges from 1 to 100 gigabases per run, with read lengths of 75 to 300 base pairs, and run times of 12 to 48 hours. Targeted panels covering 50 to several hundred genes allow high depth at low cost per sample, and multiplexing with index barcodes pools many samples. The workflow includes library preparation, quantification, loading, sequencing and bioinformatics analysis for alignment, variant calling and annotation. Infrastructure needs include data storage, compute resources and validated pipelines. Instruments intended for clinical use require verification under laboratory quality systems, with attention to accuracy, reproducibility and data privacy.

How does it work?

Molecular diagnostics amplify a specific nucleic acid sequence so that it becomes detectable. In real-time PCR, thermal cycling denatures DNA, anneals primers and extends with a DNA polymerase, while fluorescent probes such as hydrolysis probes emit signal proportional to product accumulation, and the cycle threshold indicates starting quantity. RNA targets are first reverse-transcribed. Isothermal methods such as LAMP amplify at a constant temperature of about 60–65 °C. Digital PCR partitions a sample into thousands of droplets or wells and counts positive partitions for absolute quantification. Sequencing reads the order of bases by synthesis or nanopore detection. Controls such as internal controls and no-template controls verify extraction, amplification and contamination status in each run.

What are the key features?

• Massively parallel sequencing of millions of DNA fragments per run
• Output of 1 to 100 Gb and read lengths of 75–300 bp
• Multiplexing with index barcodes to pool many samples per run
• Targeted panel, exome and transcriptome application support
• Integrated analysis software for alignment and variant calling
• Flow cell and reagent cartridges with barcoded tracking

What are the technical specifications?

A typical benchtop next-generation sequencer for clinical use configuration offers output per run of 1–100 Gb, read length of 75–300 bp (paired-end), run time of 12–48 h, reads per run of 4–400 million, base accuracy of ≥ 99.9% (Q30 ≥ 85%) and sample multiplexing of Up to 96 or more index barcodes. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Benchtop Next-Generation Sequencer for Clinical Use is used in oncology gene panel testing, inherited disease and carrier screening, pathogen genomics and surveillance, non-invasive prenatal testing and pharmacogenomics. Across the wider Molecular Diagnostics class, laboratories also deploy it for infectious disease PCR testing, oncology mutation testing and genetic and inherited disease testing.

Which standards and certifications apply?

Relevant standards and methods include ISO 15189, IEC 61010-2-101, CLSI MM03, CLSI MM06, CLSI EP17, ISO 20395, ISO 13485 and ISO 17822. Certification candidates for this model are CE, ISO 13485 quality system and NMPA registration; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Molecular laboratories require unidirectional workflow with separate areas for reagent preparation, sample processing, amplification and post-amplification where applicable, or closed systems that reduce contamination risk. Use dedicated pipettes, filter tips, UV decontamination and routine surface cleaning. Calibrate thermal blocks and optical systems, and run positive, negative and internal controls in each run. Protect instruments from dust and vibration, use stable power, and follow reagent cold-chain requirements. Validate assays and instrument performance according to CLSI MM guidelines and laboratory procedures under ISO 15189. Manage biosafety for pathogen work and handle data with privacy controls, especially for genetic information.

How do I select the right Benchtop Next-Generation Sequencer for Clinical Use?

Choose a benchtop sequencer when multi-gene information is needed in one assay. Specify output, read length, samples per run, turnaround, supported applications, bioinformatics pipeline, data storage, reagent supply and local regulatory requirements for clinical use in the RFQ, and plan staff skills.

How does it compare with other Molecular Diagnostics variants?

Choose by assay type, volume and laboratory skill level. Real-time PCR suits high-volume batch testing with open or closed assays. Sample-to-answer cartridge systems offer minimal hands-on time and fast results for low-volume or urgent testing. Digital PCR suits absolute quantification, rare variant detection and minimal residual disease. Isothermal analyzers fit decentralized settings with simple instrumentation. Sequencers suit broad genetic, oncology and pathogen genomics panels. Compare channels, throughput, sample volume, limit of detection, workflow steps, contamination control, and software for result interpretation. Verify assay availability and registration in your market, open channel versatility, LIS connectivity and service support, and plan laboratory zoning and staff training.